Wound healing in diabetic conditions is severely impaired and is a major cause of extremity amputation. A cellular, tissue engineered, wound-healing product comprising of a novel matrix of electro-spun Polycaprolactone-Gelatin nano-fiber scaffold (PCG) with embedded Bone Marrow or Peripheral Blood-derived endothelial progenitor cells (BMPC) system has been developed by scientists at NCCS, for accelerated and fibrosis-free wound healing in diabetic conditions. Continue reading
Available Technology & Capabilities
NCCS Meetings Calendar
Technology Categories
- Cancer Biology (6)
- Cell Biology (2)
- Computational Biology (3)
- Genetics (3)
- Immunology (5)
- Metabolic Diseases (3)
- Microbial Biology (4)
- Neuroscience (1)
- Stem Cells (12)
Products and Services
- Biopharma (18)
- Cell Therapy (6)
- Diagnostics (2)
- In-vitro Platform (8)
- Medical Device (3)
- Nutraceutical (2)
- Regenerative medicine (3)
- Umbilical Cord Blood Banking (3)
-
Related Links